Category
Pharmaceutical Policy
2 articles
PBSprice disclosure
Pharmaceutical Price Disclosure in Australia: How the PBS Cost Reduction Mechanism Works
Australia's price disclosure regime requires pharmaceutical manufacturers to disclose actual transaction prices, triggering mandatory PBS price reductions. A policy analysis of how the mechanism works, its impact on medicine affordability, and reform priorities.
10 May 202612 min read
GLP-1semaglutide
GLP-1 Medication Shortage in Australia: Policy Failures, Access Inequity, and the Path to Reform
Australia's GLP-1 receptor agonist shortage exposes deep structural failures in medicines policy. This analysis examines the supply crisis, access inequities, the compounding pharmacy debate, and six concrete reforms needed to ensure equitable access to life-changing obesity and diabetes treatments.
26 Mar 202613 min read